Loading...

Elixinol Wellness Limited

EXL.AXASX
HealthcareDrug Manufacturers - Specialty & Generic
$0.01
$-0.00(-20.00%)

Elixinol Wellness Limited EXL.AX Peers

See (EXL.AX) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
EXL.AX$0.01-20.00%2.6M-1.20-$0.01N/A
CAU.AX$0.54N/A300.5M-16.88-$0.03N/A
AFP.AX$2.45N/A256.9M24.50$0.10+0.60%
PBP.AX$2.98-0.33%242.3M29.80$0.10+1.26%
LV1.AX$0.92N/A144.1M3.05$0.30N/A
VLS.AX$1.80N/A98M11.25$0.16+5.56%
MVP.AX$0.60-3.23%67.6M-1.76-$0.34N/A
IHL.AX$0.04-10.87%65.1M-0.03-$1.30N/A
ANP.AX$0.06-4.92%52.3M-2.90-$0.02N/A
VIT.AX$0.07-4.29%44.4M6.70$0.01N/A
Showing 1 to 10 of 29 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

EXL.AX vs CAU.AX Comparison

EXL.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EXL.AX stands at 2.6M. In comparison, CAU.AX has a market cap of 300.5M. Regarding current trading prices, EXL.AX is priced at $0.01, while CAU.AX trades at $0.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EXL.AX currently has a P/E ratio of -1.20, whereas CAU.AX's P/E ratio is -16.88. In terms of profitability, EXL.AX's ROE is -0.20%, compared to CAU.AX's ROE of +0.34%. Regarding short-term risk, EXL.AX is more volatile compared to CAU.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EXL.AX.

Stock Price Comparison

Loading...

Frequently Asked Questions